Skip to search formSkip to main contentSkip to account menu

Carbidopa 10 MG / Levodopa 100 MG Oral Tablet

Known as: CARBIDOPA 10MG/LEVODOPA 100MG TAB [VA Product], CARBIDOPA 10/LEVODOPA 100MG TAB, CARBIDOPA 10MG/LEVODOPA 100MG TAB,UD 
National Institutes of Health

Related topics

Related topics

18 relations
Aluminum OxideBrilliant blue FCFCarbidopaCarbidopa / Levodopa

Broader (1)

Antiparkinson Agents

Narrower (1)

Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson’s disease
ABSTRACT Introduction: Parkinson’s disease is a chronic, neurodegenerative disease entity with heterogeneous features and course… 
Review
2019
Review
2019
Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson’s Disease
An enteral suspension (ES)/intestinal gel formulation of levodopa/carbidopa (hereafter referred to as levodopa/carbidopa ES… 
2018
2018
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Low dose, dispersible, levodopa/carbidopa microtablets with an automatic dose dispenser have been developed to facilitate… 
2017
2017
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
BackgroundMotor function assessments with rating scales in relation to the pharmacokinetics of levodopa may increase the… 
2015
2015
Gastroretentive carbidopa/levodopa, DM‐1992, for the treatment of advanced Parkinson's disease
This study was undertaken to compare efficacy, tolerability, and pharmacokinetics of DM‐1992, an extended‐release formulation of… 
2015
2015
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
(18)F-fluorodihydroxyphenylalanine (FDOPA) PET seems to be of limited value to localize pancreatic insulin-secreting tumors in… 
2012
2012
Feasibility of carbidopa premedication in pediatric patients: a pilot study.
AIM To verify the potential role and feasibility of carbidopa premedication in pediatric patients undergoing ¹⁸F-DOPA (Fluorine… 
Highly Cited
2002
Highly Cited
2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics
Abstract—The authors studied the pharmacokinetics of levodopa (LD) with and without pramipexole (PPX) in men and postmenopausal… 
1978
1978
Need for uncombined carbidopa to treat parkinsonism
1978
1978
Need for uncombined carbidopa to treat parkinsonism
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)